What is Milestone Pharmaceuticals Inc?
, a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 64.74M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 0 |
| 3-6months | 0 | 0 |
| 6-9months | 136,500 shares $82k | 0 |
| 9-12months | 10416,327 shares $935k | 0 |